Style | Citing Format |
---|---|
MLA | Hayat SMG, et al.. "Recombinant Protein Expression in Escherichia Coli (E.Coli): What We Need to Know." Current Pharmaceutical Design, vol. 24, no. 6, 2018, pp. 718-725. |
APA | Hayat SMG, Farahani N, Golichenari B, Sahebkar A (2018). Recombinant Protein Expression in Escherichia Coli (E.Coli): What We Need to Know. Current Pharmaceutical Design, 24(6), 718-725. |
Chicago | Hayat SMG, Farahani N, Golichenari B, Sahebkar A. "Recombinant Protein Expression in Escherichia Coli (E.Coli): What We Need to Know." Current Pharmaceutical Design 24, no. 6 (2018): 718-725. |
Harvard | Hayat SMG et al. (2018) 'Recombinant Protein Expression in Escherichia Coli (E.Coli): What We Need to Know', Current Pharmaceutical Design, 24(6), pp. 718-725. |
Vancouver | Hayat SMG, Farahani N, Golichenari B, Sahebkar A. Recombinant Protein Expression in Escherichia Coli (E.Coli): What We Need to Know. Current Pharmaceutical Design. 2018;24(6):718-725. |
BibTex | @article{ author = {Hayat SMG and Farahani N and Golichenari B and Sahebkar A}, title = {Recombinant Protein Expression in Escherichia Coli (E.Coli): What We Need to Know}, journal = {Current Pharmaceutical Design}, volume = {24}, number = {6}, pages = {718-725}, year = {2018} } |
RIS | TY - JOUR AU - Hayat SMG AU - Farahani N AU - Golichenari B AU - Sahebkar A TI - Recombinant Protein Expression in Escherichia Coli (E.Coli): What We Need to Know JO - Current Pharmaceutical Design VL - 24 IS - 6 SP - 718 EP - 725 PY - 2018 ER - |